Alphamab Oncology (HK:9966) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Alphamab Oncology has appointed Mr. Cho Man as a non-executive director and a member of its strategy committee, effective October 22, 2024, bringing his extensive experience in the pharmaceutical industry to the company. The company also announced the resignation of Ms. Wang Jin’nan as joint company secretary due to other work commitments. These changes are part of Alphamab’s strategic efforts to strengthen its leadership team for future growth.
For further insights into HK:9966 stock, check out TipRanks’ Stock Analysis page.